Regencell Bioscience
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-03-31 |
|---|---|---|---|
EBITDA | -1,853 | -2,177 | -1 |
EBIT | -2,424 | -1 | |
Net Income | -1,853 | -2,235 | -1 |
Cash | 2,961 | 2,961 | |
Basic Shares | 13,012 | 494,488 | 494,472 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -745 | -769 | -604 | -26 |
EBITDA | -3,617 | -5,292 | -6,990 | -1,354 |
EBIT | -4,363 | -6,062 | -7,594 | -1,381 |
Net Income | -4,301 | -5,871 | -7,422 | -1,346 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,007 | -4,990 | -6,047 | -767 |
Cash | 2,961 | 1,564 | 6,416 | 59 |
Basic Shares | 494,488 | 494,488 | 494,488 | 480,399 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | $0 |
2024-09-30 | $0 |
2022-09-30 | -$0.30 |
2022-03-31 | -$0.29 |
